VB

Venkata Bhaskara Murthy Penumarthi

Active Director Designated Partner DIN 08326172
DIN 08326172 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Bhaskara Murthy Penumarthi

Data last updated:

Venkata Bhaskara Murthy Penumarthi is a Designated Partner at Exizen Life Sciences Llp (since 2019). The company operates in Pharma.

DIN 08326172
Primary Designation Designated Partner
Industry Pharma
First Appointment 09 Jan 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Jan 20192019Active

Board colleagues of Venkata Bhaskara Murthy Penumarthi

NameDINCompanyDesignation
Satya Prasad Bhamidipati08326183Exizen Life Sciences LlpDesignated Partner
Syed Mohamed Mohsin Naqvi08385928Exizen Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Exizen Life Sciences Llp
Premium access

Shareholding and investment profile for Venkata Bhaskara Murthy Penumarthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Bhaskara Murthy Penumarthi

Venkata Bhaskara Murthy Penumarthi currently holds 1 directorship: Exizen Life Sciences Llp (Designated Partner, since 09 Jan 2019).

Venkata Bhaskara Murthy Penumarthi was first appointed on 09 Jan 2019 as Designated Partner at Exizen Life Sciences Llp.

The current boards of Venkata Bhaskara Murthy Penumarthi's companies include Satya Prasad Bhamidipati (Exizen Life Sciences Llp), Syed Mohamed Mohsin Naqvi (Exizen Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available